| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 7.964 | 28.078 | 40.291 | 55.713 | 48.598 |
| Total Income - EUR | - | - | - | 0 | 0 | 9.931 | 50.408 | 54.411 | 63.495 | 56.376 |
| Total Expenses - EUR | - | - | - | 28 | 108 | 21.812 | 49.847 | 53.580 | 62.443 | 54.301 |
| Gross Profit/Loss - EUR | - | - | - | -28 | -108 | -11.881 | 562 | 830 | 1.052 | 2.075 |
| Net Profit/Loss - EUR | - | - | - | -28 | -108 | -11.895 | 277 | 443 | 506 | 618 |
| Employees | - | - | - | 0 | 0 | 5 | 6 | 5 | 3 | 2 |
Check the financial reports for the company - Nady-Medicare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 45 | 0 | 35.470 | 33.642 | 28.790 | 110.840 | 102.584 |
| Current Assets | - | - | - | 34 | 1 | 1.486 | 10.084 | 10.995 | 16.693 | 15.237 |
| Inventories | - | - | - | 6 | 0 | 1.446 | 7.083 | 8.784 | 8.883 | 9.589 |
| Receivables | - | - | - | 0 | 0 | 0 | 745 | 1.104 | 2.176 | 3.024 |
| Cash | - | - | - | 28 | 1 | 40 | 2.256 | 1.107 | 5.634 | 2.623 |
| Shareholders Funds | - | - | - | 15 | -94 | -14.059 | -13.470 | -13.069 | -12.524 | -11.836 |
| Social Capital | - | - | - | 43 | 42 | 52 | 51 | 51 | 51 | 50 |
| Debts | - | - | - | 64 | 95 | 51.015 | 23.194 | 27.203 | 122.265 | 119.702 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 34.002 | 25.651 | 17.792 | 9.954 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nady-Medicare S.r.l.